Drug Enforcement D-0325-2024

Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.

Status

Ongoing

Classification

Class II

Report Date

February 21, 2024

Termination Date

Product Information

Product description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
Product quantity
1,299 syringes
Reason for recall
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
MN

Location & Firm

Recalling firm
IntegraDose Compounding Services LLC
Address
719 Kasota Ave Se, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-0325-2024
Event ID
93940
Recall initiation date
January 22, 2024
Center classification date
February 15, 2024
Code info
Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024
More code info